Search Results - "Abushamat, Layla A"

Break the "HOLD": The Need to Strengthen the Management of Hypertension, Obesity, Lipids, and Diabetes (HOLD) and Improve Cardiovascular Health in People With Diabetes by Abushamat, Layla A, Nambi, Vijay

Get full text

Very Unusual Sellar/Suprasellar Region Masses: A Review by Abushamat, Layla A, Kerr, Janice M, Lopes, M Beatriz S, Kleinschmidt-DeMasters, Bette K

“…The cause of sellar region masses in large retrospective series is overwhelmingly pituitary adenomas (84.6%), followed by craniopharyngiomas (3.2%), cystic…”
Get full text

Bempedoic Acid in Secondary Prevention by Mousavi, Idine, Nambi, Vijay, Abushamat, Layla A., Al-Kindi, Sadeer G., Shapiro, Michael D., Sperling, Laurence, Virani, Salim S., Minhas, Abdul Mannan Khan

“…•Bempedoic acid has been shown to reduce major adverse cardiovascular outcomes in patients unable to take statins due to statin-associated side…”
Get full text

LDL-C Lowering in Prevention of Atherosclerotic Cardiovascular Disease: Another Step Forward in This Lifelong Marathon by Nambi, Vijay, Abushamat, Layla A

Get full text

Lipid-Lowering Therapy in the Elderly: Are Current Guidelines a Sign of Ageism in Medical Care? by Ballantyne, Christie M., Varughese, Mini Grace, Abushamat, Layla A.

“…[Display omitted]…”
Get full text

Lowering LDL cholesterol in clinical practice: time for change? by Abushamat, Layla A, Ballantyne, Christie M

Get full text

The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis by Abushamat, Layla A., Shah, Pir Ahmad, Eckel, Robert H., Harrison, Stephen A., Barb, Diana

“…Metabolic dysfunction-associated steatotic liver disease (MASLD) affects 1 in 3–4 adult individuals and can progress to metabolic dysfunction-associated…”
Get full text

Curbing the Obesity Epidemic: Should GLP-1 Receptor Agonists Be the Standard of Care for Obesity? by Kaplan, Jennifer M., Zaman, Adnin, Abushamat, Layla A.

“…Purpose of Review: This article summarizes the medical management of obesity with an emphasis on incretin-based therapeutics that target the neuro-hormonal…”
Get full text

488-P: Subclinical Autonomic Neuropathy in Uncomplicated Type 2 Diabetes by JOHNSTON, ASPEN, ABUSHAMAT, LAYLA A., ENGE, DANIEL, BARKER, ALEX J., CLARK, ETHAN W., RAFFERTY, DEIRDRE, REGENSTEINER, JUDITH G., REUSCH, JANE E.B.

“…Cardiac autonomic neuropathy (CAN), a common complication of type 2 diabetes (T2D), is often not detected until late in disease progression. Autonomic nervous…”
Get full text

Evolving Concepts of Type 2 Diabetes Management by Abushamat, Layla A., Reusch, Jane E.B.

“…With the concept of patient-centered care in mind, this article outlines the current diabetes medications available for glucose lowering and the…”
Get full text

Obesity Management in Cardiometabolic Disease: State of the Art by Iwamoto, Sean J., Abushamat, Layla A., Zaman, Adnin, Millard, Anthony J., Cornier, Marc-Andre

“…Purpose of Review To summarize research from the last 5 years on the effects of weight loss treatments, including lifestyle changes, anti-obesity medications,…”
Get full text

Correlates of Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus (from the Department of Veterans Affairs) by Al Rifai, Mahmoud, Vaughan, Elizabeth M., Abushamat, Layla A., Lee, Michelle, Ramsey, David J., Gupta, Kartik, Navaneethan, Sankar D., Virani, Salim S.

“…This study used data from the Veterans Affairs administrative and clinical dataset to evaluate determinants of glucagon-like peptide-1 receptor agonist (GLP-1…”
Get full text

Trends in cardiovascular mortality in the United States from 1968 to 2019: analysis of the CDC WONDER database by Minhas, Abdul Mannan Khan, Gupta, Kartik, Jain, Vardhmaan, Kakar, Tanya Singh, Merchant, Anwar T, Shapiro, Michael D, Abushamat, Layla A, Nambi, Vijay, Virani, Salim S

Get full text

Trends in Undiagnosed Diabetes Mellitus Among United States Adults: Cross-Sectional Analyses from NHANES 2011–2020 by Gupta, Kartik, Obeidat, Liyan, Kakar, Tanya Singh, Fadel, Raef Ali, Al Rifai, Mahmoud, Abushamat, Layla A., Virani, Salim S.

“…Early detection and management of diabetes mellitus (DM) will help achieve the World Health Organization Global Action Plan target of a 25% relative reduction…”
Get full text

Unmasking Barriers in the Delivery of Preconception Counseling and Contraception Provision for Patients With Type 1 or Type 2 Diabetes by Abushamat, Layla A., Sayres, Lauren, Jeffers, Rebecca, Nielsen, Chloe, Barbour, Linda A., Zaman, Adnin

“…Suboptimal glycemic control among women with type 1 or type 2 diabetes before conception and during the early part of pregnancy is a powerful risk factor for…”
Get full text

Social Vulnerability and Cardiovascular-Related Mortality Among Older Adults in the United States by Minhas, Abdul Mannan Khan, Kobo, Ofer, Mamas, Mamas A, Al-Kindi, Sadeer G, Abushamat, Layla A, Nambi, Vijay, Michos, Erin D, Ballantyne, Christie, Abramov, Dmitry

“…The association of social vulnerability and cardiovascular disease-related mortality in older adults has not been well characterized. The Centers for Disease…”
Get full text

Sex Differences in Physical Activity Among Individuals With Type 2 Diabetes Across the Life Span: A Systematic Review and Meta-analysis by Whipple, Mary O, Pinto, Ana J, Abushamat, Layla A, Bergouignan, Audrey, Chapman, Kristina, Huebschmann, Amy G, Masters, Kevin S, Nadeau, Kristen J, Scalzo, Rebecca L, Schauer, Irene E, Rafferty, Deirdre, Reusch, Jane E B, Regensteiner, Judith G

“…Physical activity (PA) is a cornerstone of type 2 diabetes mellitus (T2DM) treatment. Sex differences in PA behavior or barriers/facilitators to PA among…”
Get full text

Single‐leg exercise training augments in vivo skeletal muscle oxidative flux and vascular content and function in adults with type 2 diabetes by Scalzo, Rebecca L., Schauer, Irene E., Rafferty, Deirdre, Knaub, Leslie A., Kvaratskhelia, Nina, Johnson, Taro Kaelix, Pott, Gregory B., Abushamat, Layla A., Whipple, Mary O., Huebschmann, Amy G., Cree‐Green, Melanie, Reusch, Jane E. B., Regensteiner, Judith G.

“…Key points People with type 2 diabetes (T2D) have impaired skeletal muscle oxidative flux due to limited oxygen delivery. In the current study, this impairment…”
Get full text

Obesity dominates early effects on cardiac structure and arterial stiffness in people with type 2 diabetes by Abushamat, Layla A, Enge, Daniel, Fujiwara, Takashi, Schäfer, Michal, Clark, Ethan W, Englund, Erin K, Scalzo, Rebecca L, Johnston, Aspen, Rafferty, Deirdre, Schauer, Irene E, Whipple, Mary O, Hunter, Kendall, Huebschmann, Amy G, Nadeau, Kristen J, Jarvis, Kelly, Barker, Alex J, Regensteiner, Judith G, Reusch, Jane E B

“…Type 2 diabetes (T2D) and obesity are global epidemics leading to excess cardiovascular disease (CVD). This study investigates standard and novel cardiac MRI…”
Get full text

Rosiglitazone improves insulin resistance but does not improve exercise capacity in individuals with impaired glucose tolerance: A randomized clinical study by Abushamat, Layla A, Schauer, Irene E, Low Wang, Cecilia C, Mitchell, Stacey, Herlache, Leah, Bridenstine, Mark, Durbin, Roy, Snell-Bergeon, Janet K, Regensteiner, Judith G, Reusch, Jane EB

“…Dysmetabolic states, such as type 2 diabetes (T2D), characterized by insulin resistance (IR), are associated with fatty liver, increased cardiovascular disease…”
Get full text